{
    "eid": "2-s2.0-85055554891",
    "title": "Risk factors for venous thromboembolism (VTE) recurrences in Thai patients without cancer",
    "cover-date": "2019-01-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Hematology",
            "@code": "2720",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [
        "Asian",
        "deep vein thrombosis",
        "pulmonary embolism",
        "recurrence",
        "risk factor",
        "Thai",
        "thrombophilia",
        "Venous thromboembolism"
    ],
    "authors": [
        "Panchalee Satpanich",
        "Ponlapat Rojnuckarin"
    ],
    "citedby-count": 8,
    "ref-count": 33,
    "ref-list": [
        "Incidence of venous thromboembolism: a community-based study in Western France",
        "A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism",
        "Incidence and cumulative recurrence rates of venous thromboembolism in the Taiwanese population",
        "Epidemiology of venous thromboembolism in a Chinese population",
        "Incidence of venous thromboembolism in Korea: from the health insurance review and assessment service database",
        "Predictors of recurrence after deep vein thrombosis and pulmonary embolism: a population-based cohort study",
        "Recurrent venous thromboembolism after deep vein thrombosis",
        "The long term clinical course of acute deep venous thrombosis",
        "Does the clinical presentation and extent of venous thrombosis predict likelihood and type of recurrence? A patient-level meta-analysis",
        "Three months versus one year of oral anticoagulant therapy for idiopathic deep venous thrombosis",
        "Post-thrombotic syndrome, recurrence, and death 10 years after the first episode of venous thromboembolism treated with warfarin for 6 weeks or 6 months",
        "Anticoagulation for three versus six months in patients with deep vein thrombosis or pulmonary embolism, or both: randomised trial",
        "Antithrombotic therapy for VTE disease: CHEST guideline and expert panel report",
        "Cancer and venous thromboembolism. Clinical implications of strong association",
        "The risk of recurrent venous thromboembolism in men and women",
        "Predicting disease recurrence in patients with previous unprovoked venous thromboembolism: a proposed prediction score (DASH)",
        "Incidence of recurrent venous thromboembolism in relation to clinical and thrombophilic risk factors: prospective cohort study",
        "Risk assessment for recurrent venous thrombosis",
        "Thrombophilia, clinical factors, and recurrent venous thrombotic events",
        "Risk factors of venous thromboembolism in Thai patients",
        "Venous thromboembolism in Asia--an unrecognised and under-treated problem?",
        "The risk of recurrent venous thromboembolism in patients with inherited deficiency of natural anticoagulants antithrombin, protein C and protein S",
        "Identifying unprovoked thromboembolism patients at low risk for recurrence who can discontinue anticoagulant therapy",
        "Risk assessment of recurrence in patients with unprovoked deep vein thrombosis or pulmonary embolism: the Vienna prediction model",
        "Systematic review of prognostic models for recurrent venous thromboembolism (VTE) post-treatment of first unprovoked VTE",
        "Incidence of idiopathic deep venous thrombosis and secondary thromboembolism among ethnic groups in California",
        "Clinical predictors of recurrent venous thromboembolism: a single institute experience in Korea",
        "International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)",
        "The risk of recurrent venous thromboembolism after discontinuing anticoagulation in patients with acute proximal deep vein thrombosis or pulmonary embolism. A prospective cohort study in 1,626 patients",
        "Thrombophilia in East Asian countries: are there any genetic differences in these countries?",
        "Protein S deficiency is common in a healthy Thai population",
        "R147w in PROC gene is a risk factor of thromboembolism in Thai children",
        "Risk of recurrent venous thromboembolism after stopping treatment in cohort studies: recommendation for acceptable rates and standardized reporting"
    ],
    "affiliation": {
        "affiliation-city": "Bangkok",
        "@id": "60022183",
        "affilname": "King Chulalongkorn Memorial Hospital",
        "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022183",
        "affiliation-country": "Thailand"
    },
    "funding": [
        "Chulalongkorn University"
    ]
}